Ryan Arthur F

Director

1 company

Insider Signal Score

Average

Trades Analyzed

12M Win Rate

37.8%

Avg 3M Return

-2.7%

Avg 12M Return

-2.1%

Ryan Arthur F serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 490 sells. Those positions are worth an estimated $11.2M at current prices.

Historically, Ryan Arthur F's trades have earned a middling insider score of 54/100 across 38 rated trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of -2.1%.

The biggest single holding is REGN (~$11.2M) as Director. The recent filings there lean toward selling, a net 14,196 shares.

Holdings by Company

REGNJul 2, 2026

Current Shares17.3K

Est. Value$11.25M

Net Activity-14,196

Bought: 0Sold: 14.2K

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 2, 2026	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	200	$650.15	$130,030.00	-1.1%	+15.9%	-
May 1, 2026	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$705.24	$70,523.80	-0.6%	+5.3%	-
Apr 1, 2026	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$777.27	$77,727.28	-0.6%	-19.8%	-
Mar 2, 2026	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$785.50	$78,549.55	-0.6%	-24.0%	-
Feb 9, 2026	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$778.53	$77,852.60	-0.6%	-8.7%	-
Oct 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	107	$1,048.14	$112,150.86	-0.6%	-32.9%	-42.7%
Sep 3, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$1,178.69	$117,868.50	-0.6%	-34.8%	-51.8%
Aug 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	83	$1,081.42	$89,758.07	-0.5%	-15.6%	-48.9%
Jul 1, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	100	$1,059.24	$105,923.96	-0.6%	-0.5%	-49.4%
Jun 3, 2024	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell10b5-1	110	$995.03	$109,452.87	-0.6%	+18.1%	-50.7%